DiscoverPsychopharmacology and Psychiatry Updates
Psychopharmacology and Psychiatry Updates
Claim Ownership

Psychopharmacology and Psychiatry Updates

Author: Psychopharmacology Institute

Subscribed: 599Played: 90,899
Share

Description

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
42 Episodes
Reverse
We review a study on the management of psychiatric disturbances in Parkinson’s Disease and atypical parkinsonisms. Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute
A 14-year-old patient with autism spectrum disorder presents to the emergency room with aggressive and agitated behavior. We discuss possible etiologies and psychosocial and pharmacologic management. Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute
We review the BAART trial on risperidone vs aripiprazole in irritability associated with autism spectrum disorder.   Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute
We discuss studies on the safety of antidepressants in pregnancy regarding autism risk, IQ, cardiac malformations, miscarriage, and neonatal mortality. Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute
We discuss a study that investigates the relationship between prenatal stress and a diagnosis of borderline personality disorder in offspring. Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute
We explore the case of Rosa, a 36 year old pregnant woman with a history of depression, we discuss how to adjust pharmacotherapy, psychotherapy and other factors to keep in mind. Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute
In this podcast episode with Dr. Jim Phelps, we review the evidence for several agents used to help patients with depression and cognitive dysfunction symptoms. We speak about modafinil, vortioxetine, duloxetine and amphetamines. Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute
In this podcast episode, we delve into the neuroprotective role of lithium in preventing dementia. We review a 2019 randomized controlled trial that administered low-dose lithium to patients with mild cognitive impairment. Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute
In this podcast episode, we review the major FDA approvals in psychopharmacology for 2019. We explore brexanolone, bremelanotide, the asenapine skin patch, esketamine, cariprazine, and lumateperone. Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute
In this podcast episode, we discuss a case of a 65-year-old patient with first-episode MDD that is treatment resistant. With the expertise of Dr. Ken Gillman, we unpack how to manage this case with an MAOI. Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute
In this podcast episode, we discuss a 2019 study that addresses the question of whether antidepressants increase dementia risk and the possible underlying mechanisms. Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute
In this podcast episode, you get to meet some of the humans of Psychopharmacology Institute. We discuss what we enjoy, what we have to offer and how you can join our team. Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute
In this podcast episode, Dr. Jim Phelps shares the findings of a tantalizing study that found that agents like allopurinol, angiotensin agents, aspirin and non-steroidals may be effective for the treatment of depression. Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute
This episode is the starter pack for the use of monoamine oxidase inhibitors in psychiatry practice. We learn the mechanism of action, food-related instructions and MAOI drug interactions. Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute
In this podcast episode, Dr. Jim Phelps reviews a meta-analysis about ketamine for suicidal ideation and how effective it is. Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute
In this podcast episode we learn the core concepts surrounding ketamine and esketamine; a very hot topic in psychiatry today. We have Dr. Sam Wilkinson and Dr. Joseph Goldberg joining us. Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute
In this podcast episode, we dig further into the practical use of pharmacogenetic testing in psychiatric practice. We address its limitations and the resources you can use to guide your decision making. Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute
In this podcast episode, we question whether pharmacogenetic testing is valuable in psychiatry practice. Joined by Dr. Simon Kung and Dr. Michael Thase, we find answers to this question! Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute
In this podcast interview with Dr. Leslie Citrome, we venture into the topic of transdermal delivery of psychotropics. We explore the challenge of creating patches and also peek into the latest antipsychotics in clinical trials for transdermal delivery. Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute
This podcast episode covers the basics of diagnosing and managing novel synthetic opioids and synthetic cathinones. Download a PDF of this interview here Become a premium member of the Psychopharmacology Institute  
loading
Comments (1)

Sam sms

Hello. My 7 year old adapted daughter had severe agitation episodes. Our paychiatriat impression was PTSD, ODD and ASD. She gave her Risperidone for 3 months which only alleviated her agreasive behaviour, but only for 2 weeks. But she got unilateral painfull Gynecomastia. Then The pschychiatrist changes that to Fluoxetine 10 mg woth breakfast and Aripiprazole 5 mg with launch. Her agitation and anger episodes got very better and her concentration and cognitive funxtion got bette, too. But she stil has difficulty communicating with her peers and episodes and mania. She is obsessive to changing her clithes and is very jealous to other children. We tried to calm the environment but her behaviours makes us as parenta and her sister very concerned. What is the best next aproach? Sam

Jun 27th
Reply
Download from Google Play
Download from App Store